ATE532516T1 - Verfahren zur synthese von glyt-1-hemmern - Google Patents
Verfahren zur synthese von glyt-1-hemmernInfo
- Publication number
- ATE532516T1 ATE532516T1 AT08709206T AT08709206T ATE532516T1 AT E532516 T1 ATE532516 T1 AT E532516T1 AT 08709206 T AT08709206 T AT 08709206T AT 08709206 T AT08709206 T AT 08709206T AT E532516 T1 ATE532516 T1 AT E532516T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- formula
- glyt
- inhibitors
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07103485 | 2007-03-05 | ||
| PCT/EP2008/052244 WO2008107334A2 (en) | 2007-03-05 | 2008-02-25 | Process for the synthesis of glyt-1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE532516T1 true ATE532516T1 (de) | 2011-11-15 |
Family
ID=39469606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08709206T ATE532516T1 (de) | 2007-03-05 | 2008-02-25 | Verfahren zur synthese von glyt-1-hemmern |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7812161B2 (show.php) |
| EP (1) | EP2131843B1 (show.php) |
| JP (1) | JP4745446B2 (show.php) |
| KR (1) | KR101143073B1 (show.php) |
| CN (1) | CN101622000B (show.php) |
| AT (1) | ATE532516T1 (show.php) |
| AU (1) | AU2008223915B2 (show.php) |
| BR (1) | BRPI0808570B8 (show.php) |
| CA (1) | CA2678630C (show.php) |
| ES (1) | ES2375585T3 (show.php) |
| IL (1) | IL200323A (show.php) |
| MX (1) | MX2009009065A (show.php) |
| WO (1) | WO2008107334A2 (show.php) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5656474B2 (ja) | 2010-06-28 | 2015-01-21 | 関東化学株式会社 | 脂肪族光学活性フルオロアルコールの製造方法 |
| CN104628679B (zh) * | 2013-11-08 | 2018-02-09 | 江苏恩华药业股份有限公司 | Bitopertin的合成方法及其中间体 |
| CN106397312B (zh) * | 2015-07-31 | 2020-03-24 | 广东东阳光药业有限公司 | 一种制备glyt-1抑制剂的方法 |
| EP4087570A4 (en) | 2020-01-09 | 2024-04-03 | Disc Medicine, Inc. | METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS |
| EP4229051A1 (en) | 2020-10-13 | 2023-08-23 | Boehringer Ingelheim International GmbH | Process of reworking |
| CN119768399A (zh) | 2022-08-24 | 2025-04-04 | 勃林格殷格翰国际有限公司 | GlyT-1抑制剂的可规模化制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
| US4480102A (en) * | 1982-07-23 | 1984-10-30 | The Dow Chemical Company | 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same |
| IE62792B1 (en) * | 1988-11-24 | 1995-03-08 | Akzo Nv | Pharmaceutical composition containing 1-(mono- or bis (Trifluoromethyl)-2-pyridinyl) piperazines |
| DE4235155A1 (de) * | 1992-10-19 | 1994-04-21 | Basf Ag | Verfahren zur Herstellung von Methylsulfonylbenzoesäuren |
| KR20010042851A (ko) * | 1998-04-20 | 2001-05-25 | 후지야마 아키라 | ｃＧＭＰ 포스포디에스터라제 억제자로서의 안트라닐산유도체 |
| DE10112040A1 (de) * | 2001-03-14 | 2002-10-02 | Aventis Pharma Gmbh | Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| CN1867554B (zh) * | 2003-08-11 | 2011-07-06 | 弗·哈夫曼-拉罗切有限公司 | 具有邻-取代的苯基的哌嗪及其作为glyt1抑制剂的用途 |
| AU2005313581B2 (en) * | 2004-12-09 | 2011-06-09 | F. Hoffmann-La Roche Ag | Phenyl-piperazin methanone derivatives |
| CA2593453A1 (en) * | 2005-01-06 | 2006-07-13 | F. Hoffmann-La Roche Ag | Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| ATE472327T1 (de) * | 2005-01-07 | 2010-07-15 | Hoffmann La Roche | Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen |
| MX2008000260A (es) * | 2005-07-08 | 2008-03-24 | Hoffmann La Roche | Reduccion asimetrica de 1,1,1-trifluoroacetona. |
-
2008
- 2008-02-25 CN CN200880006900XA patent/CN101622000B/zh active Active
- 2008-02-25 AT AT08709206T patent/ATE532516T1/de active
- 2008-02-25 EP EP08709206A patent/EP2131843B1/en active Active
- 2008-02-25 CA CA2678630A patent/CA2678630C/en active Active
- 2008-02-25 AU AU2008223915A patent/AU2008223915B2/en active Active
- 2008-02-25 JP JP2009552166A patent/JP4745446B2/ja active Active
- 2008-02-25 ES ES08709206T patent/ES2375585T3/es active Active
- 2008-02-25 BR BRPI0808570A patent/BRPI0808570B8/pt active IP Right Grant
- 2008-02-25 MX MX2009009065A patent/MX2009009065A/es active IP Right Grant
- 2008-02-25 WO PCT/EP2008/052244 patent/WO2008107334A2/en not_active Ceased
- 2008-02-25 KR KR1020097018418A patent/KR101143073B1/ko active Active
- 2008-02-27 US US12/038,006 patent/US7812161B2/en active Active
-
2009
- 2009-08-10 IL IL200323A patent/IL200323A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2678630C (en) | 2015-04-14 |
| US20080221327A1 (en) | 2008-09-11 |
| KR101143073B1 (ko) | 2012-05-08 |
| BRPI0808570B1 (pt) | 2020-09-15 |
| EP2131843B1 (en) | 2011-11-09 |
| BRPI0808570B8 (pt) | 2021-05-25 |
| CN101622000A (zh) | 2010-01-06 |
| IL200323A0 (en) | 2010-04-29 |
| WO2008107334A2 (en) | 2008-09-12 |
| US7812161B2 (en) | 2010-10-12 |
| BRPI0808570A2 (pt) | 2014-09-02 |
| JP2010520251A (ja) | 2010-06-10 |
| AU2008223915A1 (en) | 2008-09-12 |
| EP2131843A2 (en) | 2009-12-16 |
| KR20090110368A (ko) | 2009-10-21 |
| IL200323A (en) | 2013-11-28 |
| CA2678630A1 (en) | 2008-09-12 |
| CN101622000B (zh) | 2012-07-04 |
| MX2009009065A (es) | 2009-08-31 |
| AU2008223915B2 (en) | 2013-05-02 |
| WO2008107334A3 (en) | 2008-10-23 |
| JP4745446B2 (ja) | 2011-08-10 |
| ES2375585T3 (es) | 2012-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2091948T1 (sl) | Novi inhibitorji glutaminil ciklaze | |
| DK2057126T3 (da) | Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater | |
| EP2123636A4 (en) | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE | |
| ATE477234T1 (de) | Synthese von phenolischen estern von hydroxymethylphenolen | |
| CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
| ATE532516T1 (de) | Verfahren zur synthese von glyt-1-hemmern | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| MX2009013869A (es) | Proceso para hacer 2-amino-tiazolonas sustituidas. | |
| BR112013001721A2 (pt) | processo de síntese de compostos de ureia substituída | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| MX2010013758A (es) | Procedimiento para elaborar 2-amino-tiazolonas sustituidas. | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| WO2008145673A3 (de) | Verfahren zur herstellung von 4-formylaminopiperidinderivaten | |
| ATE495158T1 (de) | Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
| ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
| ATE529413T1 (de) | Verfahren zur synthese von aryloxydiaminopyrimidinen | |
| DE602007010725D1 (de) | Verfahren und zwischenprodukt zur herstellung von donezepil | |
| DE502006003346D1 (de) | Verfahren zur herstellung von beta-aminopropionsäurederivaten | |
| DE602006005230D1 (de) | Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| DE602004008486D1 (de) | Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol | |
| DE502005009501D1 (de) | Verfahren zur herstellung von candesartan | |
| ATE469141T1 (de) | Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten | |
| DE602007007773D1 (de) | Verfahren zur synthese von ibandronat-natrium | |
| ATE444964T1 (de) | 5-pyridinyl-1-azabicycloä3.2.1üoctan-derivate, herstellungsverfahren und deren verwendung für therapeutika | |
| MX351820B (es) | Proceso para preparar compuestos de bencimidazol. |